|
 |

Rafael Alfonso
Admission: Fall 2007
MD, Universidad del Rosario, Colombia
MSc, Universidad Autonoma de Barcelona, Spain
Research Interest: Evaluation of health policies, pharmacoeconomics and outcomes research in Latin American countries.
|

Joseph Babigumira
Admission: Fall 2006
MS, Health Services Research, Case Western Reserve University
MBChB, Medicine and Surgery, Mbarara University, Uganda
Research Interests : To conduct cost-effectiveness
research and to influence health policy in Uganda and other sub-Saharan
countries
|

Preeti Bajaj
Admission: Fall 2009
BS, Biomedical Engineering, Johns Hopkins University
Research Interests : Pharmacoeconomics and outcomes research locally and in resource poor countries, informed decision-making and efficiency in drug and medical device development
|

Lisa Bloudek
Admission: Fall 2009
BS, Biochemistry, University of Washington
PharmD, University of Washington
Research Interests: Pharmaceutical outcomes, cost-effectiveness analysis, modeling and outcomes related to Alzheimer’s Disease.
|

Mindy Cheng
Admission: Fall 2006
MS, Healthcare Administration, California State University, East
Bay
BS, Microbiology, University of Michigan
Research Interests: Orphan drugs- economics and outcomes, pharmacoeconomics, health policy analysis, infectious disease diagnosis and treatment
|

Patrick Gillard
Fellowship: 2009-2011
University of Washington/Allergan
Post-Doctoral Fellowship
BS, Biology/Psychology, Wheaton College
PharmD, University of Washington
Research Interests:
|

Bernardo Goulart
Admission: Fall 2008
MD, Universidade Federal do Rio de Janiero
Research Interests: Clinical outcomes in lung and head and neck cancers; cost-effectiveness of lung and head and neck cancer therapies; cancer clinical trials.
|

Katie Gries
Fellowship: 2008-2010
University of Washington/Allergan
Post-Doctoral Fellowship
BS, Biochemistry/Chemistry, University of Washington
PharmD, University of Southern California
Research Interests: Pharmaceutical outcomes; economic benefit of evidence based medicine, quality of life research that relates to drug treatment, cost-effectiveness analyses applies to oncology management
|

Ryan Hansen
Fellowship: 2007-2011
University of Washington/Abbott Laboratories
Pre-Doctoral Fellowship
BA, Chemistry/Philosophy, Carroll College
PharmD, University of Washington
Research Interests: Health economics, cost-effectiveness analyses, health and disease state modeling.
|

Elizabeth James, PhD Candidate
Admission: Fall 2004
PharmD, University of Texas, Austin
BS, Biomedical Sciences, Texas A&M University
Dissertation Title: Evaluation of a Prescription Drug Pay-for-Performance Program: Impact on prescribing trends, budget and patient outcomes
Research Interests: Pharmaceutical policy, pharmacy
practice, health insurance prescription benefit structure, clinical
trials
|
Norio Kasahara
Admission: Fall 2008
BS, Pharmacy, Tokyo University of Pharmacy & Life Sciences
MPH, Johns Hopkins University
Research Interests: Health policy analysis and pharmaceutical outcomes research; pharmaceutical regulations and policies, pharmacoeconomics, effectiveness analysis of pharmaceutical interventions, and global health.
|

Hiep Nguyen
Admission: Fall 2009
BS, Biological Sciences, University of California, Irvine
MPH, Epidemiology, Yale University
Research Interests: The impact of pharmacy benefit design changes on asthma prescription consumption, including controller medication utilization, adherence, substitution patterns, asthma health care utilization, and costs.
|

Justin Robertson
Admission: Fall 2009
BS, Mathematics, Baylor University
MA, Economics, University of Washington
PhD Student, Department of Economics, University of Washington
Research Interests: Health economics, public finance, the role of information in health care, cost-effectiveness analysis.
|

Joshua Roth
Admission: Fall 2008
MHA, University of Washington
BS, Experimental Psychology and Sociology, Union College,Schenectady, NY
Research Interests: Health technology assessment, Cost-effectiveness analysis in cancer therapeutics, Effects of changes in policy on cost and utilization of prescription medications
|

Jonathan Watanabe
Admission: Fall 2007
Fellowship: 2007-2009
University of Washington/Allergan
Post-Doctoral Fellowship
BS, Zoology, University of Washington
PharmD, University of Southern California
MS, University of Washington
Thesis Title: Cost Analysis for Interventions for Antimuscarinic Refractory Patients with Overactive Bladder
Research Interests: Payer Cost and Reimbursement Analysis, Patient Reported Outcomes and Dossier submission to FDA, Health Related Quality of Life and Utility assessment, Impact of Drug-Drug Interactions on Care
|

Catherine W. Corbell
Admission: Fall 2006
MSc, Clinical Pharmacy, University
of London
BSc, Pharmacy, University of Nairobi, Kenya
Research Interests: To create policies that will
improve access to necessary pharmaceuticals and health services
for the the people of Kenya - particularly women and children.
|

Heidi Wirtz
Admission: Fall 2008
BS, Exercise Science, University of Iowa
MS, Physiology/Exercise Science, University of Iowa
PharmD, Creighton University
Reseach Interests: Cost-effectiveness analysis of biologics and health care technology, clinical trial design, Regulatory decision-making.
|

William Wong
Admission: Fall 2009
BS, Molecular Biology, University of California, San Diego
MS, Biology, University of California, San Diego
PharmD, University of California, San Diego
Reseach Interests: Cost-effectiveness of pharmcoenetic testing and pharmacogenomics, pharmacoeconomics, health informatics, cardiovascular disease related tests and treatments.
|
|